ENTITY
Merck & Co

Merck & Co (MRK US)

244
Analysis
Health CareUnited States
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.
more
14 Nov 2018 11:30

Morningstar Management Behind the Moat 2018: Conference Highlights

Morningstar and PitchBook hosted the 10th annual Management Behind the Moat Conference in Chicago on Nov. 7 and 8, offering our institutional...

Share
bearishS&P 500 INDEX
14 Nov 2018 06:04

U.S. Equity Strategy & Sector Commentaries: Defensive Sectors Leading = Unhealthy Market

The “Big” rally has now faded less than a week from its start. While many point to a robust economy, strong GDP, and a strengthening U.S. dollar as...

Logo
481 Views
Share
bullishKyorin Holdings
05 Nov 2018 21:27

Kyorin 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Overall sales (¥50b) stayed flat as brisk uptake of Flutiform (+13% to ¥6.1b), Desalex (+200% to ¥2.8b) and Nasonex (after Merck...

bullishEisai Co Ltd
01 Nov 2018 16:45

Eisai 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Lenvima, Eisai’s key revenue driver, performed across regions (+43% to ¥14.3b in the US, +170% to ¥4.3b in Japan and +40% to ¥3.7b...

31 Oct 2018 16:39

Innovent Biologics IPO First-Day: Take Money off the Table

Despite a recent spell of lacklustre early-stage biotech flotations that have slumped post-IPO, Innovent Biologics Inc (1801 HK)'s shares popped...

Logo
663 Views
Share
x